These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6948944)

  • 1. Correction of neutropenia by portacaval shunt in type IB glycogen storage disease.
    J Pediatr; 1982 Jan; 100(1):168-9. PubMed ID: 6948944
    [No Abstract]   [Full Text] [Related]  

  • 2. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
    Burr IM; O'Neill JA; Karzon DT; Howard LJ; Greene HL
    J Pediatr; 1974 Dec; 85(6):792-5. PubMed ID: 4213651
    [No Abstract]   [Full Text] [Related]  

  • 4. Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.
    Corbeel L; Boogaerts M; Van den Berghe G; Everaerts MC; Marchal G; Eeckels R
    Eur J Pediatr; 1983; 140(3):273-5. PubMed ID: 6578929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Portacaval anastomosis for metabolic disease.
    Lancet; 1974 Aug; 2(7878):444-5. PubMed ID: 4136672
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaesthesia for portocaval bypass in patients with metabolic diseases.
    Casson H
    Br J Anaesth; 1975 Sep; 47(9):969-75. PubMed ID: 1059457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal diversion. Treatment for glycogen storage disease and hyperlipemia.
    Starzl TE; Putnam CW
    JAMA; 1975 Sep; 233(9):955-7. PubMed ID: 168416
    [No Abstract]   [Full Text] [Related]  

  • 8. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycogen storage disease treated by portacaval transposition.
    Ridell AG; Davies RP
    Proc R Soc Med; 1966 Jun; 59(6):484. PubMed ID: 5220251
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of dietary therapy and portacaval shunt in the management of a patient with type Ib glycogen storage disease.
    Borowitz SM; Greene HL; Gay JC; Neblett WW
    J Pediatr Gastroenterol Nutr; 1987; 6(4):635-9. PubMed ID: 3123638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 12. LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION.
    SEXTON AW; MARCHIORO TL; WADDELL WR; STARZL TE
    Surg Forum; 1964; 15():120-2. PubMed ID: 14189279
    [No Abstract]   [Full Text] [Related]  

  • 13. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.
    Folkman J; Philippart A; Tze WJ; Crigler J
    Surgery; 1972 Aug; 72(2):306-14. PubMed ID: 4626293
    [No Abstract]   [Full Text] [Related]  

  • 14. Portacaval shunt as treatment for glycogenosis Ib.
    Ozsoylu S
    Am J Dis Child; 1986 Apr; 140(4):324. PubMed ID: 3456699
    [No Abstract]   [Full Text] [Related]  

  • 15. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction of neutropenia associated with dysgammaglobulinemia.
    Rieger CH; Moohr JW; Rothberg RM
    Pediatrics; 1974 Oct; 54(4):508-11. PubMed ID: 4137595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Granulocyte transfusion in neutropenia and severe infection].
    Rørvik TO
    Tidsskr Nor Laegeforen; 1983 Jan; 103(3):225-6. PubMed ID: 6845326
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin therapy in childhood immune neutropenia.
    Favareto F; Molinari AC; Arigliani R; Strada P; Reali G; Mori PG
    Haematologica; 1987; 72(5):473-4. PubMed ID: 3121475
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutropenia in a patient with essential cryoglobulinemia type 1: rapid reversal by plasmapheresis.
    Schifferli JA; Berclaz R; Ryser JE; Blanc E
    Am J Med; 1989 Jan; 86(1):139-40. PubMed ID: 2491931
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose intravenous gamma globulin for autoimmune neutropenia.
    Pollack S; Cunningham-Rundles C; Smithwick EM; Barandun S; Good RA
    N Engl J Med; 1982 Jul; 307(4):253. PubMed ID: 6178028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.